FdaApplication

NDA 020067

Back to search

Identifiers

Properties

PropertyValue
applicant_nameATNAHS PHARMA US LTD
application_typeNDA
approval_date1994-10-14

Products (2)

ProductActive ingredientStrengthDosage form
EC-NAPROSYNNAPROXEN500MGTABLET, DELAYED RELEASE;ORAL
EC-NAPROSYNNAPROXEN375MGTABLET, DELAYED RELEASE;ORAL

2 products